Concepedia

Carl Hay

CH

19

Publications

2.5K

Citations

17

H-Index

1997

Active since

Affiliations

Research Institute for Genetic and Human Therapy(Current)

AstraZeneca (United States)

The University of Queensland

Novartis (United States)

QIMR Berghofer Medical Research Institute

Carl Hay is an author at Research Institute for Genetic and Human Therapy specializing in medicine, tumor biology, and immunology.

Top concepts

MedicineImmunologyTumor BiologyCell BiologyCancer ResearchTumor MicroenvironmentImmunotherapyOncologyCancer BiologyTumor Immunity

Publications per year

1997–2020

19

Publications

19

Dopaminergic Neurons Protected from Degeneration by GDNF Gene Therapy

DL Choi-Lundberg, Qing Lin, Yung‐Nien Chang et al. · Science · 1997 · 631 citations

Da Neurons, Neurodegenerative Diseases, Progressive Degeneration +12

Complete genome sequence analysis of Seneca Valley virus-001, a novel oncolytic picornavirus

Laura M. Hales, Nick J. Knowles, P. Seshidar Reddy et al. · Journal of General Virology · 2008 · 374 citations

Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses

Arabella Young, Shin Foong Ngiow, Deborah S. Barkauskas et al. · Cancer Cell · 2016 · 373 citations · Full text

Cancer Immunosurveillance, Immunology, Tumor Immunity +11

Targeting CD73 in the tumor microenvironment with MEDI9447

Carl Hay, Erin Sult, Qihui Huang et al. · OncoImmunology · 2016 · 281 citations · Full text

Seneca Valley Virus, a Systemically Deliverable Oncolytic Picornavirus, and the Treatment of Neuroendocrine Cancers

P. Seshidhar Reddy, Kevin D. Burroughs, Laura M. Hales et al. · JNCI Journal of the National Cancer Institute · 2007 · 250 citations · Full text

Rows per page

1–5 of 19